Abstracts tagged "Advocacy"

Abstract Number: PP06 • 2018 ACR/ARHP Annual Meeting
Learning to Self-Advocate in the Transition from Pediatric to Adult Lupus Care
Denita Perry¹ and Diane Gross², ¹Unaffiliated, Joilet, IL, ²Lupus Research Alliance, New York, NY
Background/Diagnosis: I was diagnosed with lupus at age 15. I was starting my sophomore year of high school and noticed a rash that the doctor…
Abstract Number: PP09 • 2018 ACR/ARHP Annual Meeting
Improved Quality of Life and Decreased Symptoms of Lupus with Diet, Exercise, and Functional Medicine
Marisa Zeppieri-Caruana, Lupus Chick, New York, NY
Background/Diagnosis: Like most people who live with a chronic illness and/or autoimmune disease, my story started long before I realized. Symptoms came and went throughout…
Abstract Number: PP12 • 2018 ACR/ARHP Annual Meeting
Living a Full Life with A.S. Through Adaptations
Gail Wright, Spondylitis Association of America, Buffalo Grove, IL
Background/Diagnosis: After running a half marathon and 2 5’ks, I had unexplained back/ hip pain that wouldn’t resolve. I returned to my PT. After 3…
Abstract Number: 362 • 2017 ACR/ARHP Annual Meeting
Patients’ Experiences and Attitudes about Non-Medical Switching of Biologics: Results from an Online Patient Survey
Amanda Teeple¹, Lorie A. Ellis², Laura Huff³, Chuck Reynolds³, Seth D. Ginsberg⁴, Leah McCormick Howard⁵, Danielle Walls⁶ and Jeffrey R. Curtis⁷, ¹Janssen Scientific Affairs, LLC, Horsham, PA, ²Health Economics & Outcomes Research, Janssen Scientific Affairs, LLC, Horsham, PA, ³Benfield | Arthur J. Gallagher & Co., Webster Groves, MO, ⁴Global Healthy Living Foundation, CreakyJoints, Upper Nyack, NY, ⁵National Psoriasis Foundation, Portland, OR, ⁶BDJ Solutions, Melrose, MA, ⁷Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Health insurance plan designs often have benefits that result in highly prescriptive patient (pt) treatment options that can result in switching of patient’s medications…
Abstract Number: 1053 • 2017 ACR/ARHP Annual Meeting
Impact of Step Therapy Protocols on North Carolina Rheumatologists’ Job Satisfaction and the Quality of Care Received By Their Patients with Rheumatoid Arthritis
Victoria Hamby¹, Amanda Nelson², Antonia Bennett¹, Leigh F. Callahan³ and Stacie Dusetzina⁴, ¹Gillings School of Global Public Health, Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC, ²Division of Rheumatology, Allergy, and Immunology and Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, ³Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, ⁴Eshelman School of Pharmacy and Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC
Background/Purpose: Early diagnosis and treatment of rheumatoid arthritis (RA) is crucial in minimizing disease damage. Step-therapy, a form of prior authorization used by payers to…
Abstract Number: 1150 • 2016 ACR/ARHP Annual Meeting
Advocacy 101: Engaging Rheumatology Fellows in Health Policy and Advocacy
Sarah Doaty¹, Sharon L. Kolasinski², William F. Harvey³, Adam Cooper⁴ and E. Blair Solow⁵, ¹Rheumatology, UCLA, Los Angeles, CA, ²Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, ³Rheumatology, Tufts Medical Center, Boston, MA, ⁴American College of Rheumatology, Atlanta, GA, ⁵Rheumatology, UT Southwestern Medical Center, Dallas, TX
Background/Purpose: Healthcare delivery and health policies in the United States are evolving rapidly. Rheumatology fellowship programs lack formal curricular content to educate trainees about legislative…
Abstract Number: 3230 • 2015 ACR/ARHP Annual Meeting
Perceived Barriers in Care for Arthritis
Elizabeth M. Badley¹, Lynn Moore² and Monique A.M. Gignac³, ¹Toronto Western Research Institute, Toronto, ON, Canada, ²The Arthritis Society, Toronto, ON, Canada, ³Instititue for Work and Health, Toronto, ON, Canada
Background/Purpose: To examine current arthritis treatments, barriers to treatment, and perceptions of health care decision making, especially preferences for patient-physician shared input. Methods: A poll…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].